Prognostic significance of anti-p53 and anti-KRas circulating antibodies in esophageal cancer patients treated with chemoradiotherapy

BACKGROUND: P53 mutations are an adverse prognostic factor in esophageal cancer. P53 and KRas mutations are involved in chemo-radioresistance. Circulating anti-p53 or anti-KRas antibodies are associated with gene mutations. We studied whether anti-p53 or anti-KRas auto-antibodies were prognostic fac...

Descripción completa

Detalles Bibliográficos
Autores principales: Blanchard, Pierre, Quero, Laurent, Pacault, Vincent, Schlageter, Marie-Helene, Baruch-Hennequin, Valerie, Hennequin, Christophe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3338390/
https://www.ncbi.nlm.nih.gov/pubmed/22448886
http://dx.doi.org/10.1186/1471-2407-12-119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3338390/
https://www.ncbi.nlm.nih.gov/pubmed/22448886
http://dx.doi.org/10.1186/1471-2407-12-119

Ejemplares similares